Back to ALNY Stock Lookup
Pages: 1 2 »» Last Page

ALNY – Analyst Ratings

Feb 24, 2014 11:07 AM Tekmira Pharma (TKMR) Jumps as Maxim Group Nearly Doubles Price Target
Feb 14, 2014 02:18 PM Alnylam Pharmaceuticals (ALNY) Weakness is Buying Opportunity, Says Deutsche Bank
Feb 14, 2014 07:29 AM Alnylam Pharmaceuticals (ALNY) Target Lifted to $94 at Needham & Company
Jan 17, 2014 09:27 AM Alnylam Pharma (ALNY) Target Raised to $108 at Deutsche Bank
Jan 14, 2014 06:51 AM Morgan Stanley Downgrades Alnylam Pharmaceuticals (ALNY) to Equalweight
Jan 13, 2014 12:40 PM S&P Capital IQ Downgrades Alnylam Pharmaceuticals (ALNY) to Neutral
Nov 14, 2013 11:47 AM Alnylam (ALNY): Leerink Swann Says Diflunisal Data De-Risks Patisiran
Sep 24, 2013 08:15 AM Alnylam (ALNY) Target Raised to $80 at Deutsche Bank
Sep 23, 2013 02:42 PM Alnylam (ALNY) PT Lifted to $65 at Needham & Company on Positive ALN-TTRsc Results
Sep 23, 2013 01:48 PM Alnylam (ALNY) Target Raised to $80 at Leerink Swann
Aug 9, 2013 08:39 AM Needham & Company Lifts PT on Alnylam Pharmaceuticals (ALNY) to $55
Jul 12, 2013 01:54 PM Alnylam (ALNY) Price Target Raised to $60 at Deutsche Bank
Jul 11, 2013 09:23 AM Alnylam (ALNY) Has Potential 'Home Run' With ALN-TTRsc, Analyst Says
Jun 11, 2013 07:39 AM Morgan Stanley Starts Alnylam Pharmaceuticals (ALNY) at Overweight
May 24, 2013 07:17 AM Deutsche Bank Starts Alnylam Pharmaceuticals (ALNY) at Buy
Feb 8, 2013 07:18 AM JMP Securities Starts Alnylam Pharmaceuticals (ALNY) at Market Outperform
Feb 4, 2013 03:02 PM Needham & Company Boosts Alnylam (ALNY) PT to $28 on Medicines Co. Deal
Dec 12, 2012 06:41 AM Piper Jaffray Upgrades Alnylam Pharmaceuticals (ALNY) to Overweight
Aug 28, 2012 03:45 PM Leerink Swann Maintains Bullish Stance on Alnylam Pharmaceuticals (ANLY), Sees Dramatic Upside
Aug 7, 2012 09:02 AM Needham & Company Reiterates Buy on Alnylam Pharmaceuticals (ALNY), Says Stock Undervalued
Jul 17, 2012 07:49 AM Leerink Swann Starts Alnylam Pharmaceuticals (ALNY) at Outperform; Positive Phase 1 Results From ALN-TTR-02
Jul 16, 2012 02:28 PM Alnylam Pharmaceuticals (ALNY) Price Target Boosted at Needham & Company
May 30, 2012 01:09 PM Needham & Company Reiterates a 'Buy' on Alnylam Pharma (ALNY); Phase 2b Trial Misses, But Shares Still Undervalued
May 8, 2012 08:06 AM JPMorgan Starts Alnylam Pharmaceuticals (ALNY) at Overweight
May 4, 2012 09:11 AM Needham & Company Reiterates a 'Buy' on Alnylam Pharmaceuticals (ALNY); Focused on Development
Feb 10, 2012 09:35 AM Needham & Company Reiterates a 'Buy' on Alnylam Pharmaceuticals (ALNY); Accelerated ALN-TTR Development May Sustain Stock Momentum in 2012
Jan 4, 2012 11:57 AM Needham & Company Reiterates a 'Buy' on Alnylam (ALNY); Positive Results for ALN-PCS; Stock Remains a 2012 Favorite
Dec 23, 2011 07:35 AM Needham & Company 2012 Biotech Preview
Dec 15, 2011 10:51 AM JMP Securities Starts Alnylam Pharmaceuticals (ALNY) at Market Outperform
Nov 21, 2011 11:31 AM Needham & Company Reiterates a 'Buy' on Alnylam Pharmaceuticals (ALNY); Encouraging Clinical Data from ALN-TTR Program
Nov 2, 2011 08:19 AM Needham & Company Reiterates a 'Buy' on Alnylam Pharmaceuticals (ALNY); Initial Proof-of-Concept Data from Two Programs Expected by YE11
Oct 14, 2011 07:50 AM Rodman & Renshaw Starts Alnylam Pharmaceuticals (ALNY) at Market Outperform
Sep 22, 2011 01:59 PM Needham & Company Maintains a 'Buy' on Alnylam Pharmaceuticals (ALNY); Favorable View Based on Low Valuation
Aug 16, 2011 07:23 AM Piper Jaffray Upgrades Alnylam Pharmaceuticals (ALNY) to Overweight
May 6, 2011 09:38 AM McNicoll Lewis & Vlak Starts Alnylam Pharmaceuticals (ALNY) at Buy; Investing in the Next Leap of Human Therapeutics with RNA Interference (RNAi)
May 3, 2011 07:47 AM Needham & Company Reiterates a 'Buy' on Alnylam Pharmaceuticals (ALNY); Q1 Review
Feb 23, 2011 07:57 AM Needham & Company Upgrades Alnylam Pharmaceuticals (ALNY) to 'Buy' Based on Expected 2011 Clinical Pipeline News Flow and Low Valuation
Feb 18, 2011 07:56 AM Roth Capital Upgrades Alnylam Pharmaceuticals (ALNY) to Buy
May 20, 2010 08:05 AM ThinkEquity Initiates Coverage on Alnylam Pharmaceuticals (ALNY) with a Buy
Nov 24, 2009 08:37 AM Roth Capital Downgrades Alnylam Pharmaceuticals (ALNY) to Hold. Price Target Cut
Jul 14, 2009 07:30 AM Leerink Swann Upgrades Alnylam Pharmaceuticals (ALNY) to Market Perform; Good Progress Demonstrated
Jun 10, 2009 07:55 AM Roth Capital Initiates Coverage on Alnylam Pharmaceuticals (ALNY) with a Buy
Jun 10, 2009 07:53 AM Jefferies & Co Initiates Coverage on Alnylam Pharmaceuticals (ALNY) with a Buy
Feb 25, 2009 08:36 AM Needham & Co Upgrades Alnylam Pharmaceuticals (ALNY) to Hold Based on Valuation and Pipeline Progress
Sep 12, 2008 07:53 AM Thomas Weisel Initiates Coverage on Alnylam Pharm (ALNY) with a Marketweight
Sep 12, 2008 07:43 AM Thomas Weisel Starts Alnylam Pharmaceuticals (ALNY) at Market Weight
Aug 20, 2008 08:25 AM Leerink Swann Starts Alnylam Pharmaceuticals (ALNY) at Underperform
Mar 3, 2008 08:13 AM Needham & Co Downgrades Alnylam (ALNY) to Underperform
Dec 5, 2007 12:17 PM Cantor Fitzgerald Raises Price Target on Alnylam Pharmaceuticals (ALNY)
Oct 10, 2007 07:26 AM Piper Jaffray & Co. Downgrades Alnylam Pharmaceuticals (ALNY) to Market Perform
Pages: 1 2 »» Last Page

Back to ALNY Stock Lookup